1. Home
  2. FMBH vs FTRE Comparison

FMBH vs FTRE Comparison

Compare FMBH & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

N/A

Current Price

$50.68

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

N/A

Current Price

$18.41

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FMBH
FTRE
Founded
1865
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
FMBH
FTRE
Price
$50.68
$18.41
Analyst Decision
Hold
Buy
Analyst Count
5
9
Target Price
$43.40
$14.06
AVG Volume (30 Days)
93.3K
1.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
2.33%
N/A
EPS Growth
16.06
N/A
EPS
2.10
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$9.30
N/A
Revenue Next Year
$6.66
$3.09
P/E Ratio
$24.11
N/A
Revenue Growth
N/A
1.00
52 Week Low
$34.51
$8.31
52 Week High
$53.36
$21.39

Technical Indicators

Market Signals
Indicator
FMBH
FTRE
Relative Strength Index (RSI) 57.39 53.83
Support Level $50.49 $16.45
Resistance Level $53.36 $19.34
Average True Range (ATR) 0.91 0.76
MACD -0.10 -0.00
Stochastic Oscillator 74.84 74.66

Price Performance

Historical Comparison
FMBH
FTRE

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: